These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36677616)

  • 1. Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors.
    Khan S; Ullah H; Taha M; Rahim F; Sarfraz M; Iqbal R; Iqbal N; Hussain R; Ali Shah SA; Ayub K; Albalawi MA; Abdelaziz MA; Alatawi FS; Khan KM
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
    Hussain R; Ullah H; Rahim F; Sarfraz M; Taha M; Iqbal R; Rehman W; Khan S; Shah SAA; Hyder S; Alhomrani M; Alamri AS; Abdulaziz O; Abdelaziz MA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Hussain R; Rahim F; Ullah H; Khan S; Sarfraz M; Iqbal R; Suleman F; Al-Sadoon MK
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
    Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
    Rahim F; Ullah H; Taha M; Hussain R; Sarfraz M; Iqbal R; Iqbal N; Khan S; Ali Shah SA; Albalawi MA; Abdelaziz MA; Alatawi FS; Alasmari A; Sakran MI; Zidan N; Jafri I; Khan KM
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease.
    Rahim F; Javed MT; Ullah H; Wadood A; Taha M; Ashraf M; Qurat-ul-Ain ; Khan MA; Khan F; Mirza S; Khan KM
    Bioorg Chem; 2015 Oct; 62():106-16. PubMed ID: 26318401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses.
    Zaib S; Younas MT; Khan I; Ali HS; McAdam CJ; White JM; Jaber F; Awwad NS; Ibrahium HA
    Bioorg Chem; 2023 Dec; 141():106868. PubMed ID: 37738768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Evaluation of Anti-Cholinesterase Activity, in Silico Molecular Docking Studies, and DFT Calculations of Green Synthesized Thiadiazolo[3,2-a]pyrimidine Derivatives.
    Pouramiri B; Rashidi M; Lotfi S; Mohammadi M; Rabiei K
    Chem Biodivers; 2023 Nov; 20(11):e202301193. PubMed ID: 37869899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches.
    Anwar S; Rehman W; Hussain R; Khan S; Alanazi MM; Alsaif NA; Khan Y; Iqbal S; Naz A; Hashmi MA
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
    Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
    Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
    Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
    Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
    Sahin Z; Ertas M; Bender C; Bülbül EF; Berk B; Biltekin SN; Yurttaş L; Demirayak Ş
    Drug Dev Res; 2018 Dec; 79(8):406-425. PubMed ID: 30343499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti-Alzheimer agents.
    Eissa KI; Kamel MM; Mohamed LW; Galal MA; Kassab AE
    Drug Dev Res; 2022 Sep; 83(6):1394-1407. PubMed ID: 35749685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
    Abdpour S; Jalili-Baleh L; Nadri H; Forootanfar H; Bukhari SNA; Ramazani A; Ebrahimi SES; Foroumadi A; Khoobi M
    Bioorg Chem; 2021 May; 110():104750. PubMed ID: 33691251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.